Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Chest
|
July 24, 1998
The pressure-overloaded right ventricle in pulmonary hypertension
M R Bristow, L S Zisman, B D Lowes, et al.
Circulation
|
October 15, 1995
Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage
M White, R J Wiechmann, R L Roden, et al.
Kidney International
|
December 16, 1998
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy
A B Chapman, W T Abraham, S Zamudio, et al.
Circulation Research
|
April 29, 2000
Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure
L E Wagoner, L L Craft, B Singh, et al.
Cardiology
|
January 1, 1995
Importance of angiotensin-converting enzyme in pulmonary hypertension
W T Abraham, M V Raynolds, B Gottschall, et al.
The Journal of Clinical Investigation
|
September 1, 1995
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway
L S Zisman, W T Abraham, G E Meixell, et al.
Circulation
|
December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators
M R Bristow, E M Gilbert, W T Abraham, et al.
Heart (British Cardiac Society)
|
July 9, 2010
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT
R J van Bommel, J Gorcsan, E S Chung, et al.
The New England Journal of Medicine
|
July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
W S Colucci, U Elkayam, D P Horton, et al.
Circulation
|
February 15, 2001
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality
R Dash, V Kadambi, A G Schmidt, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Chest
|
July 24, 1998
The pressure-overloaded right ventricle in pulmonary hypertension
M R Bristow, L S Zisman, B D Lowes, et al.
Circulation
|
October 15, 1995
Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage
M White, R J Wiechmann, R L Roden, et al.
Kidney International
|
December 16, 1998
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy
A B Chapman, W T Abraham, S Zamudio, et al.
Circulation Research
|
April 29, 2000
Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure
L E Wagoner, L L Craft, B Singh, et al.
Cardiology
|
January 1, 1995
Importance of angiotensin-converting enzyme in pulmonary hypertension
W T Abraham, M V Raynolds, B Gottschall, et al.
The Journal of Clinical Investigation
|
September 1, 1995
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway
L S Zisman, W T Abraham, G E Meixell, et al.
Circulation
|
December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators
M R Bristow, E M Gilbert, W T Abraham, et al.
Heart (British Cardiac Society)
|
July 9, 2010
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT
R J van Bommel, J Gorcsan, E S Chung, et al.
The New England Journal of Medicine
|
July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
W S Colucci, U Elkayam, D P Horton, et al.
Circulation
|
February 15, 2001
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality
R Dash, V Kadambi, A G Schmidt, et al.
Page
of 6